Clinical Trials Browser

Phase 3 × Active not recruiting × fluzoparib × Clear all

NCT04691804 2024-12-31

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 3 Active not recruiting

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

NCT06612814 2024-09-25

PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer

Phase 3 Active not recruiting

Breast Cancer Metastatic